G-BA - Gemeinsamer Bundesausschuss

searchGbaBenefitAssessments

Free

Search German G-BA early benefit assessment decisions (AMNOG, § 35a SGB V) by active substance (INN), trade name, ATC code, indication, added-benefit category and decision date. Returns, for each decision, the added-benefit category and certainty per patient group vs the appropriate comparator therapy. Use the decisionIds with getGbaBenefitAssessment for endpoint results and G-BA's reasons. Only decisions still in force are covered (repealed or superseded ones are dropped by G-BA); indication texts are in German, and substance matching tolerates English INN spelling (semaglutide finds Semaglutid). Prefer atcCode for cross-country joins.

Try it

Open in playground
kirha tools run gba_searchGbaBenefitAssessments \
  --input '{}'

Uses the key saved by kirha auth login.

  • activeSubstancestring

    INN or trade name, e.g. pembrolizumab, Keytruda. Matches the assessed substance, not comparators

  • addedBenefitstring[]

    One of major, considerable, minor, nonQuantifiable, notProven, deemedProven, deemedNotProven, lesserBenefit

  • atcCodestring

    ATC code or prefix, e.g. L01FF02 or L01FF

  • decidedAfterstring

    YYYY-MM-DD

  • decidedBeforestring

    YYYY-MM-DD

  • indicationstring

    German words or ICD-10 name matched in indication and patient groups, e.g. Melanom, Mammakarzinom

  • limitnumber, default 10, 1 to 25
  • offsetnumber, default 0, Min 0
  • orphanOnlyboolean